New Lung Cancer Guidelines Help but Gaps in Care Remain

Sylvester Game Changer vehicle staff flashing the U hand symbol in front of the vehicle.
Summary
  • Lung cancer is the leading cause of cancer deaths in the United States.
  • Updated guidelines for lung cancer screenings have improved access, but gaps in care remain.
  • Sylvester Comprehensive Cancer Center researchers found that uninsured patients, those without a primary care provider and those who live in rural areas were less likely to get screened.

Lung cancer is the leading cause of cancer deaths in the United States for both men and women. Lung cancer screenings can save lives by finding cancer early and making treatment more effective. Updated guidelines for lung cancer screenings have improved access to this life-saving procedure, but gaps in care remain, according to a new study published today in JAMA.

“The updated guidelines substantially increased lung cancer screenings overall, even as cancer screenings declined during the COVID-19 pandemic,” said senior author Tracy Crane, Ph.D., RDN, associate professor and co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. “However, discrepancies for who is screened persist, underscoring the importance of addressing structural barriers in rural and underserved populations.”

Sylvester Comprehensive Cancer Center researcher Dr. Tracy Crane
Dr. Tracy Crane stresses the importance of addressing structural barriers to cancer screening.

Low-dose computed tomography is a relatively new screening for early-stage lung cancer. The U.S. Preventive Services Task Force (USPSTF) issued its first lung cancer screening guidelines in 2013. These screens are quick and painless. In 2021, the USPSTF updated the guidelines to start screening at 50 instead of 55 and to include those with less of a smoking history (20 or more pack-years instead of 30 or more).

First author LaShae Rolle, M.P.H., CPH, a Sylvester doctoral research fellow, used data on health-related risks and behaviors from a nationally representative CDC survey. The dataset is large, but habits and risks are self-reported. Participants may underestimate how much they’ve smoked or report their habits inaccurately.

Rolle found that, of the people classified as high-risk before the guidelines changed, only 15.43% were up to date on their lung cancer screenings. The year after the guidelines changed, 47.08% of those eligible were up to date. Better, but still less than half. The numbers were lower in uninsured patients, those without a primary care provider and those who live in rural areas.

Barriers to Cancer Care

Patients without a primary care provider were much less likely to get screened, and one barrier may be the requirement for a referral. In other cases, the barrier may be knowledge. These patients may not even know they’re eligible for screening.

Sylvester Game Changer mobile screening vehicle
Game Changer vehicles offer cancer screening education to high-risk patients.

Other barriers include the cost of care. Rolle found that health insurance pays for 97% of lung cancer screenings. Without insurance, a scan can cost hundreds of dollars, in addition to paying for a doctor’s visit to obtain a referral.

There are often options to access free or low-cost scans. Many states and nonprofits have programs to defer costs and increase access.

“But screening is not a one-time deal. Patients should get a scan annually, and results may require additional testing,” study author Coral Olazagasti, M.D., a Sylvester assistant professor of clinical medical oncology, said. “The costs come not only from the scan but the follow-up.”

Sylvester Comprehensive Cancer Center's Dr. Coral Olazagasti
Dr. Coral Olazagasti says that the cumulative costs of cancer screening can discourage people from annual scans.

“A person may say, ‘I don’t have the money. I don’t have insurance.’ But no one thinks they have cancer,” Rolle said. “I am a cancer survivor myself. I was diagnosed at 26. I understand how easy it is to brush off a screening, especially among those choosing between having food or getting screened.”

In rural areas, screening facilities may be hundreds of miles apart, making travel a barrier for many. Mobile lung cancer screening units can bring access to rural areas but cost up to $2 million.

Closing the Cancer Screening Gap

At Sylvester, community outreach teams work to close the gaps in lung cancer screenings.

“We have been identifying the places in our catchment area where the highest-risk patients are not getting screened. We then head over in the Game Changer bus and educate and counsel the public on lung cancer screenings,” said study author Estelamari Rodriguez, M.D., M.P.H., Sylvester’s associate director of community outreach for thoracic oncology.

Dr. Estelamari Rodriguez
Dr. Estelamari Rodriguez points to outreach efforts as ways to increase knowledge about the importance of cancer screenings.

Other ways to increase screening rates is to include patient navigators who can help educate patients, schedule their scans and arrange transportation.

“Partnering with local community organizations, churches and health workers has proven effective in promoting lung cancer screening,” study author Gilberto Lopes, M.D., Sylvester’s chief of the division of medical oncology, associate director and medical director for international affairs, said. “Trusted local figures can help overcome mistrust and fear while providing culturally tailored education.”

Dr. Gilberto Lopes
Dr. Gilberto Lopes says Sylvester’s partnerships with local organizations has helped screening promotional efforts.

The gaps in access to lung cancer screening are personal to Rolle.

“I was lucky enough to catch my breast cancer early, and now I’m cancer-free. I would love for others to get screened so they can catch cancer early, too,” she said.


Tags: cancer research, cancer screening, community outreach, Dr. Coral Olazagasti, Dr. Estelamari Rodriguez, Dr. Gilberto Lopes, Dr. Tracy Crane, Game Changer, lung cancer, Sylvester Comprehensive Cancer Center